Nemus Bioscience

    OverviewSuggest Edit

    Nemus Bioscience Inc. is a biopharmaceutical company focused on discovering, developing and commercializing new chemical entities from a class of chemically diverse compounds called cannabinoids. These molecules display pleiotropic activity by virtue of selectively binding to two types of cannabinoid receptors (CB1 and CB2 receptors) located throughout multiple organ systems in the body. The Company is developing novel and proprietary classes of product candidates that are designed to improve therapeutic options through enhanced chemical engineering that allow drug candidates to have more predictable bioavailability and pharmacokinetics leading to optimized efficacy and safety.

    ... Show more
    TypePublic
    Founded2012
    HQCosta Mesa, US
    Websitenemusbioscience.com

    Latest Updates

    Employees (est.) (Feb 2019)3
    Revenue (FY, 2013)$339.9 K

    Nemus Bioscience Office Locations

    Nemus Bioscience has an office in Costa Mesa
    Costa Mesa, US (HQ)
    1100 600 Anton Blvd
    Show all (1)
    Report incorrect company information

    Nemus Bioscience Financials and Metrics

    Nemus Bioscience Revenue

    Nemus Bioscience's revenue was reported to be $339.93 k in FY, 2013
    USD

    EBIT (Q2, 2018)

    (2.3m)

    Cash (30-Jun-2018)

    1.9m
    Annual
    USDFY, 2013FY, 2015FY, 2016FY, 2017

    Revenue

    339.9k

    General and administrative expense

    28.5k3.7m3.5m3.5m

    R&D expense

    576.1k939.0k311.3k

    Operating expense total

    347.2k4.3m4.5m3.9m
    Quarterly
    USDQ1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018

    Revenue

    63.4k72.8k71.1k

    General and administrative expense

    8.6k7.1k9.2k872.6k1.3m744.0k1.1m1.0m775.6k1.3m670.3k673.1k1.2m

    R&D expense

    37.2k43.4k152.3k135.4k460.0k80.5k92.1k60.7k88.6k25.0k

    Operating expense total

    64.7k86.3k67.0k909.8k1.4m896.3k1.2m1.5m856.1k1.4m730.9k761.6k1.3m
    Annual
    USDFY, 2013FY, 2015FY, 2016FY, 2017

    Cash

    52.2k3.2m64.8k260.0k

    Accounts Receivable

    236.4m

    Current Assets

    106.1k3.5m279.5k555.8k

    PP&E

    13.4k9.6k1.4k
    Quarterly
    USDQ1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018

    Cash

    46.5k50.0k39.2k176.7k601.3k4.3m2.1m831.7k319.9k380.3k108.9k42.0k2.9m1.9m

    Current Assets

    103.7k87.9k78.6k431.1k785.5k4.5m2.3m1.0m635.2k575.9k445.0k306.1k3.2m2.0m

    PP&E

    12.0k19.0k16.7k16.0k20.8k16.9k13.0k7.2k4.7k2.6k2.1k5.0k

    Total Assets

    140.8k122.7k167.6k468.7k820.8k4.5m2.3m1.1m692.1k617.4k484.0k343.0k3.2m2.0m
    Annual
    USDFY, 2013FY, 2015FY, 2016FY, 2017

    Net Income

    (3.8k)(4.8m)(3.2m)(3.1m)

    Depreciation and Amortization

    10.9k10.0k14.9k8.0k

    Accounts Payable

    10.8k(274.1k)149.3k(173.7k)

    Cash From Operating Activities

    (14.5k)(3.7m)(3.6m)(3.3m)
    Quarterly
    USDQ1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018

    Net Income

    3.6k(10.0k)(2.2k)(910.2k)(3.0m)(4.1m)(1.7m)(1.1m)(2.1m)(1.3m)(2.0m)(2.5m)(8.2m)(10.9m)

    Depreciation and Amortization

    2.4k4.7k7.9k2.3k4.6k7.3k3.7k7.6k11.5k2.4k4.9k6.8k331.0813.0

    Accounts Payable

    (2.3k)(1.1k)(9.0k)(21.4k)(113.6k)(267.3k)12.0k57.9k262.0k(47.5k)404.8k715.5k(2.2k)(89.0k)

    Cash From Operating Activities

    (4.1k)(832.0)7.1k(751.7k)(1.3m)(2.6m)(1.1m)(2.4m)(2.9m)(816.4k)(1.1m)(1.2m)(1.1m)(2.1m)
    USDY, 2018

    Financial Leverage

    -0.2 x
    Show all financial metrics
    Report incorrect company information

    Nemus Bioscience Online and Social Media Presence

    Embed Graph
    Report incorrect company information

    Nemus Bioscience News and Updates

    Nemus Bioscience Signs Agreement with Pharmaceuticals International Inc. to Develop Dosage Formulation for Human Dosing with NB1111 for Glaucoma

    Long Beach, CA - (NewMediaWire) - February 14, 2019 - Nemus Bioscience, Inc. (OTCQB: NMUS), a biopharmaceutical company focused on bioengineered cannabinoid-based therapeutics to address global medical indications, announced today that it has signed an agreement with Pharmaceuticals Internation…

    Nemus Bioscience to Present at BIO CEO & Investor Conference

    LONG BEACH, CA - (NewMediaWire) - February 07, 2019 -  Nemus Bioscience, Inc. (OTCQB: NMUS), a biopharmaceutical company focused on bioengineered cannabinoid-based therapeutics to address global medical indications, announced today that CEO and Chief Medical Officer, Dr. Brian Murphy, will pres…

    Nemus Bioscience to Present at the NobleCon XV and 8th Annual Glaucoma 360 New Horizons Forum

    Long Beach, CA - (NewMediaWire) - January 23, 2019 - Nemus Bioscience, Inc. (OTCQB: NMUS), a biopharmaceutical company focused on bioengineered cannabinoid-based therapeutics to address global medical indications, announced today that CEO and Chief Medical Officer, Dr. Brian Murphy, will presen…

    Nemus Bioscience to Present at the 2nd Annual Sachs Neuroscience Innovation Forum and Biotech Showcase 2019

    Long Beach, CA - (NewMediaWire) - January 03, 2019 - Nemus Bioscience, Inc. (OTCQB: NMUS), a biopharmaceutical company focused on bioengineered cannabinoid-based therapeutics to address global medical indications, announced today that CEO and Chief Medical Officer, Dr. Brian Murphy, will presen…

    Nemus Bioscience to Present at Investment and Scientific Conferences in December

    Long Beach, CA, Nov. 29, 2018 (NewMediaWire) -- Nemus Bioscience, Inc. (OTCQB: NMUS), a biopharmaceutical company focused on bioengineered cannabinoid-based therapeutics to address global medical indications, announced today that CEO and Chief Medical Officer Dr. Brian Murphy will present a cor…

    Nemus Bioscience to Present at BIO Investor Forum

    LONG BEACH, CA - (NewMediaWire) - October 15, 2018 - Nemus Bioscience, Inc. (OTCQB: NMUS), focused on the development of cannabinoid-based therapeutics to address global medical indications, especially those of unmet medical need, announced today that Dr. Brian Murphy, Chief Executive Officer a…
    Show more
    Report incorrect company information

    Nemus Bioscience Company Life and Culture

    Report incorrect company information

    Nemus Bioscience Frequently Asked Questions

    • When was Nemus Bioscience founded?

      Nemus Bioscience was founded in 2012.

    • How many employees does Nemus Bioscience have?

      Nemus Bioscience has 3 employees.

    • Who are Nemus Bioscience competitors?

      Competitors of Nemus Bioscience include Tilray, Canopy Growth and HERB.

    • Where is Nemus Bioscience headquarters?

      Nemus Bioscience headquarters is located at 1100 600 Anton Blvd, Costa Mesa.

    • Where are Nemus Bioscience offices?

      Nemus Bioscience has an office in Costa Mesa.

    • How many offices does Nemus Bioscience have?

      Nemus Bioscience has 1 office.